Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center collaborate with doctors and researchers the world over to provide advanced care in more specialties and subspecialties, more expertise in every facet of care for cancer and blood disorders and more cutting-edge treatment options. Thanks in part to these collaborations, we're introducing promising new drugs and opening worldwide clinical trials that break new ground across the spectrum of cancer and blood disorders - like our protocols for targeted for relapsed acute lymphoblastic leukemia, molecular profiling of brainstem gliomas, bone marrow transplantation for dyskeratosis congentia and immunotherapy for relapsed neuroblastoma.
Stay informed about our clinical trials and ongoing research. Sign up to receive our email newsletter.
Dr. Stuart Orkin, Chair of Pediatric Oncology, describes the outstanding oncology and hematology resources available at Dana-Farber/Boston Children's.